BeOne Medicines
ONC
#638
Rank
โ‚น3.295 T
Marketcap
โ‚น29,777
Share price
-1.91%
Change (1 day)
76.57%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): โ‚น59.27

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is โ‚น58.40. In 2024 the company made an earnings per share (EPS) of -โ‚น560.68.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น59.27-110.57%
2024-โ‚น560.68
2022-โ‚น1,75228.21%
2021-โ‚น1,367-19.96%
2020-โ‚น1,70820.81%
2019-โ‚น1,41331.52%
2018-โ‚น1,075417.57%
2017-โ‚น207.63-37.16%
2016-โ‚น330.44158.95%
2015-โ‚น127.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น85.36-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น21.56-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA